GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cytori Cell Research Institute Inc (TSE:3750) » Definitions » EV-to-Revenue

Cytori Cell Research Institute (TSE:3750) EV-to-Revenue : 8.15 (As of May. 30, 2024)


View and export this data going back to 2004. Start your Free Trial

What is Cytori Cell Research Institute EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Cytori Cell Research Institute's enterprise value is 円15,528 Mil. Cytori Cell Research Institute's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was 円1,904 Mil. Therefore, Cytori Cell Research Institute's EV-to-Revenue for today is 8.15.

The historical rank and industry rank for Cytori Cell Research Institute's EV-to-Revenue or its related term are showing as below:

TSE:3750' s EV-to-Revenue Range Over the Past 10 Years
Min: -0.19   Med: 3.27   Max: 53.55
Current: 8.15

During the past 13 years, the highest EV-to-Revenue of Cytori Cell Research Institute was 53.55. The lowest was -0.19. And the median was 3.27.

TSE:3750's EV-to-Revenue is ranked worse than
50.48% of 1034 companies
in the Biotechnology industry
Industry Median: 7.98 vs TSE:3750: 8.15

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-30), Cytori Cell Research Institute's stock price is 円950.00. Cytori Cell Research Institute's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was 円213.31. Therefore, Cytori Cell Research Institute's PS Ratio for today is 4.45.


Cytori Cell Research Institute EV-to-Revenue Historical Data

The historical data trend for Cytori Cell Research Institute's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cytori Cell Research Institute EV-to-Revenue Chart

Cytori Cell Research Institute Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.47 11.99 14.42 14.05 8.16

Cytori Cell Research Institute Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.33 8.16 8.06 9.94 9.04

Competitive Comparison of Cytori Cell Research Institute's EV-to-Revenue

For the Biotechnology subindustry, Cytori Cell Research Institute's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cytori Cell Research Institute's EV-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cytori Cell Research Institute's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Cytori Cell Research Institute's EV-to-Revenue falls into.



Cytori Cell Research Institute EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Cytori Cell Research Institute's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=15527.916/1904.465
=8.15

Cytori Cell Research Institute's current Enterprise Value is 円15,528 Mil.
Cytori Cell Research Institute's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円1,904 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cytori Cell Research Institute  (TSE:3750) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Cytori Cell Research Institute's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=950.00/213.307
=4.45

Cytori Cell Research Institute's share price for today is 円950.00.
Cytori Cell Research Institute's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円213.31.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cytori Cell Research Institute EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Cytori Cell Research Institute's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Cytori Cell Research Institute (TSE:3750) Business Description

Traded in Other Exchanges
N/A
Address
1-1-1 Otemachi, Otemachi Park Building, Chiyoda-ku, Tokyo, JPN, 100-0004
Cytori Cell Research Institute Inc developing a new clinical approach to cell therapy to provide better medical care to patients by providing medical care that responds to unmet medical needs based on innovative regenerative medicine. Its product pipeline includes Habeo; ECCO-50 and others.

Cytori Cell Research Institute (TSE:3750) Headlines

No Headlines